Rating Change
Oppenheimer reiterated its Outperform rating on Pulse Biosciences, Inc. (NASDAQ:PLSE) on October 13, 2026.
reiterateNASDAQ:PLSE
Oppenheimer Reiterates Outperform Rating on Pulse Biosciences, Inc. (PLSE)
Oppenheimer reiterated its Outperform rating on Pulse Biosciences, Inc. (NASDAQ:PLSE) on October 13, 2026.
At publication ·
What changed
Pulse Biosciences, Inc. (NASDAQ:PLSE) · reiterate
- Firm
- Oppenheimer
- Rating
- Outperform to Outperform
- Price at event
- $49.31
- Market capitalization
- $933.2M
At a glance
Key takeaways
- Oppenheimer reiterated an Outperform rating on Pulse Biosciences (PLSE) on October 13, 2026.
Market Context
Pulse Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $49.31 with a market capitalization of $933.2M. The stock has gained 210.5% over the past 52 weeks.
Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Pulse Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Pulse Biosciences, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 13, 2026 | Oppenheimer | Outperform | N/A |
| Oct 06, 2026 | Canaccord Genuity | Buy | N/A |
| Sep 23, 2026 | BTIG | Buy | N/A |
| Sep 09, 2026 | Freedom Capital Markets | Buy | N/A |
| Aug 17, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PLSE Stock Page
Frequently Asked Questions
What does the Outperform rating mean for PLSE?
A rating of Outperform from Oppenheimer reflects the analyst's outlook on Pulse Biosciences, Inc. (NASDAQ:PLSE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PLSE forecast page.